| Trustees and advisors | ||
|---|---|---|
| Board ofTrustees' report |
2-13 | |
| Independent auditor's |
report | 14-16 |
| Statement offinancial | activities | 17 |
| Summary income and |
expenditure | 19 |
| Balance sheet | 20 | |
| Statement ofcash flows | 21 | |
| Notes to the financial | statements | 22-38 |
| Difficult economic environment | Difficult economic environment | Difficult economic environment | Monthly | SMT review of income and | SMT review of income and | expenditure; |
|---|---|---|---|---|---|---|
| significantly | impacts financial | security of | Fundraising | Strategy and increased | capacity in |
|
| organisation. | Fundraising | Team; Finance and Fundraising reports to |
||||
| FKGP. | ||||||
| Reserves | and cash position | insufficient | Reserves | policy reviewed annually |
by F8GP; cashflow | |
| to meet commitments. | report quarterly to FKGP; medium term strategy to build |
|||||
| reserves. |
| ical Advisory Group provides invaluab rent members ofthis group are: |
le clinical advice to inform and |
|---|---|
| Dr Kate Adams | Dr Adrian Palfreeman |
| Professor Jane Anderson | Nicky Perry |
| Dr Tristan Barber | Dr lain Reeve |
| Dr Dan Clutterbuck | Dr Ann Sullivan |
| Ceri Evans | Dr Shema Tariq |
| Dr William Ford-Young |
Dr Steve Taylor |
| Jamie Hardie | Dr Lee Winter |
| Dr Christian Jessen | Sarah Zetler |
| Eileen Nixon |
| Current financial year | ||||||
|---|---|---|---|---|---|---|
| Unrestricted | Restricted | Endowment | Total | Total | ||
| funds | funds | funds | ||||
| Notes | 2022-23 f |
2022-23 | 2022-23 | 2022-23f | 2021-22 | |
| Income from: | ||||||
| Donations and legacies |
3 | 514,104 | 306,490 | 820,594 | 663,454 | |
| Charitable activities |
4 | 307,757 | 307,757 | 157,241 | ||
| Investments | 5 | 5,318 | 2,427 | 7,745 | 2,897 | |
| Total income and endowments | 827,179 | 306,490 | 2,427 | 1,136,096 | 823,592 | |
| ~E* Cht |
||||||
| Raising funds | 6 | 288,377 | 840 | 289,217 | 194,166 | |
| Charitable activities |
7 | 520,900 | 323,477 | 844,377 | 781,588 | |
| Total expenditure | 809,277 | 323,477 | 840 | 1,133,594 | 975,754 | |
| Net movement in funds |
17,902 | (16,987) | 1,587 | 2,502 | (152,162) | |
| Fund balances at 1 July 2022 | 531,098 | 115,325 | 259,242 | 905,665 | 1,057,827 | |
| Fund balances at30June 2023 | 549,000 | 98,338 | 260,829 | 908,167 | 905,665 |
| Prior financial | year | |||||
|---|---|---|---|---|---|---|
| Unrestricted | Restricted | Endowment | Total | |||
| funds | funds | funds | ||||
| 2021-22 | 2021-22 | 2021-22 | 2021-22 | |||
| Notes | 6 | 6 | f | |||
| Income from: | ||||||
| Donations and |
legacies | 427,141 | 236,313 | 663,454 | ||
| Charitable activities |
157,241 | 157,241 | ||||
| Investments | 2,804 | 93 | 2,897 | |||
| Total income and endowments | 587,186 | 236,406 | 823,592 | |||
| ~E«dit | ||||||
| Raising funds | 6 | 194,166 | 194,166 | |||
| Charitable activities |
7 | 585,487 | 196,101 | 781,588 | ||
| Total expenditure | 779,653 | 196,101 | 975,754 | |||
| Net movement | in funds | (192,467) | 40,305 | (152,162) | ||
| Fund balances | at1 July 2021 | 723,565 | 75,020 | 259,242 | 1,057,827 | |
| Fund balances at 30June 2022 | 531,098 | 115,325 | 259,242 | 905,665 |
| 2022-23 | 2021-22 | |||
|---|---|---|---|---|
| f | ||||
| Gross income | 1,133,669 | 823,592 | ||
| Total expenditure | from income funds | 1,132,754 | 975,754 | |
| Net income/(expenditure) | forthe year | 915 | (152,162) |
| 2022-23 | 2021-22 | |||
|---|---|---|---|---|
| Notes | f | |||
| Fixed assets | ||||
| Tangible assets | 13 | 18,786 | 10,546 | |
| Endowment investment |
14 | 260,829 | 259,242 | |
| 279,615 | 269,788 | |||
| Current assets | ||||
| Stocks | 15 | 13,961 | 13,939 | |
| Debtors falling due | after one year | 16 | 4,136 | 4,136 |
| Debtors falling due | within one year | 16 | 227,473 | 198,781 |
| Cash at bank and | in hand | 568,879 | 480,623 | |
| 814,449 | 697,479 | |||
| Creditors: amounts falling due within |
||||
| one year | 17 | (185,897) | (61,602) | |
| Net current assets | 628,552 | 635,877 | ||
| Total assets less | current liabilities | 908,167 | 905,665 | |
| Capital funds | ||||
| Permanent endowment |
21 | 260,829 | 259,242 | |
| income funds | ||||
| Restricted funds | 23 | 98,338 | 115,325 | |
| Unrestricted funds |
—general | 549,000 | 531,098 | |
| 908,167 | 905,665 |
| 2022-23 | 2021-22 | ||||||
|---|---|---|---|---|---|---|---|
| Notes | 'Z | ||||||
| Cash flows from operating | activities | ||||||
| Cash generated from/(absorbed operations |
by) | 27 | 99,402 | (313,058) | |||
| Investing activities |
|||||||
| Purchase oftangible fixed | assets | (17,305) | (7,075) | ||||
| Proceeds on disposal oftangible assets |
fixed | 156 | |||||
| Interest received | 7,745 | 2,897 | |||||
| Net cash used in investing | activities | (9,560) | (4,022) | ||||
| Net increase/(decrease) equivalents |
in | cash and cash | 89,842 | (317,080) | |||
| Cash and cash equivalents | at beginning | ofyear | 739,865 | 1,056,945 | |||
| Cash and cash equivalents | at | end ofyear | 829,708 | 739,865 | |||
| Relating to: Cash at bank and in hand |
568,879 | 480,623 | |||||
| Deposits included in fixed -endowment |
asset | investments | 260,829 | 259,242 | |||
| 829,708 | 739,865 |
| Donations and legacies | |||
|---|---|---|---|
| Total | Total | ||
| 2022-23 | 2021-22 | ||
| 8 | f | ||
| Grants (E5,000+)plus all pharmaceutical Other grants and donations Donated goods and services |
grants | 362,371 457,100 1,123 |
340,833 274,358 48,263 |
| 820,594 | 663,454 |
| Donations and legacies |
(Continued) | |||
| 2022-23 | 2021-22 | |||
| 8 | f | |||
| Grants (F5,000+)plus all | pharmaceutical | grants | ||
| Gilead Sciences Ltd | 15,538 | 72,988 | ||
| The Baring Foundation | 31,200 | |||
| IAS Society | 8,982 | |||
| Viva Glam | 50,000 | |||
| ViiV Healthcare UK Limited |
89,663 | 89,663 | ||
| National Lottery Fund |
81,588 | |||
| Mill Charitable Trust |
20,000 | 30,000 | ||
| Trust for London | 60,000 | 8,500 | ||
| Martin Bowley Charitable Trust |
5,000 | |||
| City Bridge Trust | 12,390 | 23,500 | ||
| Janssen-Cilag Ltd |
4,000 | |||
| Merck, Sharpe &Dohme Ltd | 1,250 | |||
| Swarovski Foundation |
42,850 | |||
| Africa Advocacy | 36,761 | 11,250 | ||
| Paper and Pixels donated | WAD website | 4,000 | ||
| Latham 8 Watkins donated | legal services | 44,263 | ||
| The Evan Cornish Foundation | 8,082 | |||
| 362,371 | 389,096 | |||
| Other grants and donations | ||||
| Individual 8 community |
133,765 | 102,888 | ||
| Corporate donations |
283,358 | 85,557 | ||
| Trusts 8 foundations | 3,260 | |||
| Legacies | 39,977 | 82,653 | ||
| 457,100 | 274,358 |
| 2022-23 | 2021-22 | ||||||
|---|---|---|---|---|---|---|---|
| f. | f | ||||||
| European international |
project funding | 141,049 | 130,223 | ||||
| Royal Free London NHS Foundation | Trust | —Fast Track Cities | 131,215 | ||||
| Gilead Sciences Ltd & | ViiV | Healthcare | UK | Ltd joint HIV outcomes project | 98,000 | ||
| Less; deferred income |
(90,326) | ||||||
| 279,938 | 130,223 | ||||||
| Awareness raising through |
red dbbon | products | 24,837 | 22,366 | |||
| Other income | 2,982 | 4,652 | |||||
| 307,757 | 157,241 |
| Endowment | Total | ||
|---|---|---|---|
| funds | |||
| 2022-23 | 2021-22 | ||
| F | |||
| Interest | receivable | 2,427 | 2,897 |
| Raising fu | nds | |||||
|---|---|---|---|---|---|---|
| Unrestricted | Endowment | Total | Total | |||
| funds | funds | |||||
| general | ||||||
| 2022-23 | 2022-23 | 2022-23 | 2021-22 | |||
| f | f | |||||
| Fundraising | salaries | 167,169 | 167,169 | 119,473 | ||
| Associated | operating | costs | 34,434 | 34,434 | 17,174 | |
| Support costs | 86,774 | 86,774 | 57,519 | |||
| Charitable | fundraising | costs | 288,377 | 288,377 | 194,166 | |
| Endowment | legal fees | 840 | ||||
| 288,377 | 840 | 289,217 | 194,166 |
| 7 | Charitable activities |
|||
|---|---|---|---|---|
| 2022-23 | 2021-22 | |||
| f | ||||
| Policy work 8 campaigning | ||||
| Staff costs | 427,130 | 448,006 | ||
| Other direct charitable | expenditure | 133,497 | 69,880 | |
| 560,627 | 517,886 | |||
| Share ofsupport costs (see note 10) | 221,713 | 215,687 | ||
| Share ofgovernance | costs (see note 10) | 62,037 | 48,015 | |
| 844,377 | 781,588 | |||
| Analysis by fund |
||||
| Unrestricted funds - general |
520,900 | 585,487 | ||
| Restricted funds | 323,477 | 196,101 | ||
| 844,377 | 781,588 |
| 2022-23 | 2021-22 | |||||
|---|---|---|---|---|---|---|
| F | 8 | |||||
| Direct | Support | Total | Direct | Support | Total | |
| Charitable | Costs | Costs | Charitable | Costs | Costs | |
| Stop | 123,338 | 62,425 | 185,763 | 160,545 | 81,748 | 242,292 |
| Champion | 50,456 | 25,538 | 75,994 | 56,967 | 29,007 | 85,975 |
| Protect | 207,432 | 104,988 | 312,419 | 108,756 | 55,377 | 164,133 |
| Drive | 179,401 | 90,800 | 270,201 | 191,618 | 97,570 | 289,188 |
| 560,627 | 283,750 | 844,377 | 517,886 | 263,702 | 781,588 |
| Support costs | |||||||
|---|---|---|---|---|---|---|---|
| Support | Governance | 2022-23 Support | costs | Governance | 2021-22 | ||
| costs | costs | costs | |||||
| f | |||||||
| Staff costs | 161,899 | 52,189 | 214,088 | 91,878 | 39,629 | 131,507 | |
| Depreciation | 9,064 | 9,064 | 13,072 | 13,072 | |||
| Non salary staffing & recruitment costs |
41,498 | 41,498 | 17,926 | 17,926 | |||
| Office expenditure | 9,261 | 9,261 | 6,436 | 6,436 | |||
| Telephone &internet Website & IT |
2,790 27,716 |
2,790 27,716 |
3,562 26,279 |
3,562 26,279 |
|||
| Premises expenditure | 50,971 | 50,971 | 64,795 | 64,795 | |||
| Insurance | 3,066 | 3,066 | 2,797 | 2,797 | |||
| Professional fees |
2,222 | 2,222 | 2,498 | 2,498 | |||
| Donated legal fees for office move |
43,963 | 43,963 | |||||
| Audit fees | 7,200 | 7,200 | 6,960 | 6,960 | |||
| Legal and professional | 339 | 339 | 724 | 724 | |||
| Trustees' meetings training |
and | 2,309 | 2,309 | 702 | 702 | ||
| 308,487 | 62,037 | 370,524 | 273,206 | 48,015 | 321,221 | ||
| Analysed between Fundraising |
86,774 | 86,774 | 57,519 | 57,519 | |||
| Charitable activities |
221,713 | 62,037 | 283,750 | 215,687 | 48,015 | 263,702 | |
| 308,487 | 62,037 | 370,524 | 273,206 | 48,015 | 321,221 |
| Number ofe The average |
mployees staff headcount duding the year was as follows: |
||
|---|---|---|---|
| 2022-23 | 2021-22 | ||
| Number | Number | ||
| 20 | 19 | ||
| Employment | costs | 2022-23 | 2021-22 |
| f | |||
| Wages and salaries | 699,753 | 604,578 | |
| Social security costs | 69,190 | 57,795 | |
| Other pension costs | 39,444 | 36,613 | |
| 808,387 | 698,986 | ||
| Total | Total | ||
| Employment | costs by department | 2022-23 | 2021-22 |
| f | f | ||
| Core policy work | 427,130 | 448,006 | |
| Fundraising | 167,169 | 119,473 | |
| Support &governance | 214,088 | 131,507 | |
| 808,387 | 698,986 |
| 2022-23 | 2021-22 |
|---|---|
| Number | Number |
| 1 | 1 |
| 13 | Tangible fixed assets | Tangible fixed assets | |||
|---|---|---|---|---|---|
| Equipment, | fixtures and fittings | ||||
| Cost | |||||
| At 1 July 2022 Additions |
77,623 17,305 |
||||
| Disposals | (5,841) | ||||
| At 30June 2023 | 89,087 | ||||
| Depreciation and impairment |
|||||
| At 1 July 2022 Depreciation charged |
in the year | 67,078 9,064 |
|||
| Eliminated in respect |
ofdisposa le | (5,841) | |||
| At 30June 2023 | 70,301 | ||||
| Carrying amount At 30June 2023 |
18,786 | ||||
| At 30June 2022 | 10,546 | ||||
| 14 | Fixed asset investments | ||||
| Cash | |||||
| E | |||||
| Cost or valuation | |||||
| At 1 July 2022 8 30June 2023 | 259,242 | ||||
| Carrying amount | |||||
| At 30June 2023 | 259,242 | ||||
| At 30June 2022 | 259,242 | ||||
| 15 | Stocks | ||||
| 2022-23 E |
2021-22f | ||||
| Stocks ofRed Ribbon lapel pins and brooches | 13,961 | 13,939 |
| 16 | Debtors | ||||
|---|---|---|---|---|---|
| 2022-23 | 2021-22 | ||||
| Amounts falling due |
within one year: | f | |||
| Grants and donations | invoiced | 207 | 5,900 | ||
| VAT recoverable | 7,499 | ||||
| Donations and grants | accrued income | 165,154 | 117,091 | ||
| Legacies due | 38,977 | 62,383 | |||
| Prepayments | 15,636 | 13,407 | |||
| 227,473 | 198,781 | ||||
| 2022-23 | 2021-22 | ||||
| Amounts falling due |
after more than one year: | f | |||
| Rent deposit | 4,136 | 4,136 | |||
| Total debtors | 231,609 | 202,917 | |||
| 17 | Creditors: amounts | falling due within one year | |||
| 2022-23 | 2021-22 | ||||
| Notes | f | f | |||
| Other taxation and social security | 14,790 | 19,143 | |||
| Deferred income | 18 | 90,326 | |||
| Trade creditors | 29,086 | 8,382 | |||
| Other creditors | 2,393 | 1,694 | |||
| Accruals and other creditors | 49,302 | 32,383 | |||
| 185,897 | 61,602 | ||||
| 18 | Deferred income | ||||
| 2022-23 | 2021-22 | ||||
| Arising from deferred | income | 90,326 |
| non-cancellable operating leases, which fall due as follow |
s: | |
|---|---|---|
| 2022-23 | 2021-22 | |
| 2 | f | |
| Within one year Between two and five years |
14,829 339 |
38,754 11,595 |
| 15,168 | 50,349 |
| Movement | Movement | |||||
|---|---|---|---|---|---|---|
| in funds | in funds | |||||
| Balance at | Incoming | Balance al | Incoming | Balance at | ||
| 1 July 2021 6 |
resources | 1July 2022 f |
resources 6 |
30June 2023 6 |
||
| Permanent | endowments | |||||
| Gary Philipp | Endowment | 259,242 | 259,242 | 2,427 | 260,829 | |
| 259,242 | 259,242 | 2,427 | 260,829 |
| 22 | Total return on endowment | Total return on endowment | Total return on endowment | ||||
|---|---|---|---|---|---|---|---|
| Opening | value ofendowment: | 259,242 | |||||
| Unapplied | total return | ||||||
| Total | 259,242 | ||||||
| Movement | in unapplied total |
return and endowment | in the year: | ||||
| Investment | return: dividends | and interest | 2,427 | ||||
| Investment | management costs |
—legal fees to establish | the fund | (840) | |||
| Total | 1,587 | ||||||
| Unapplied | total return allocated | to income | |||||
| Net movement in the reporting |
period | 1,587 | |||||
| Closing value ofpermanent | endowment | ||||||
| Gift component ofpermanent |
endowment | 259,242 | |||||
| Unapplied | total return | 1,587 | |||||
| Total | 260,829 |
| e N 0 O 0 td C Q Id 0 |
e N 0 O 0 td C Q Id 0 |
C! | O O 0O |
0 | O N N (D |
||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| e | |||||||||||||||||||||||||||||
| CI | |||||||||||||||||||||||||||||
| O D | Cd Cl |
O OO O |
O 0 Cd |
||||||||||||||||||||||||||
| Cd | |||||||||||||||||||||||||||||
| Ol C |
N III |
O Cd tD |
dC Cd |
O Q |
Cd CO ID |
QC! CD |
CD (D |
O Cd |
|||||||||||||||||||||
| N (0 |
«I | Cd | C | Ol CD |
(D C! |
||||||||||||||||||||||||
| N0 N0 Ct C |
N dl |
||||||||||||||||||||||||||||
| O.0 m Cl |
N cd O |
OlC | O R | 0 | O | ||||||||||||||||||||||||
| V | Cd | ||||||||||||||||||||||||||||
| K. e |
N | ||||||||||||||||||||||||||||
| g | I | ||||||||||||||||||||||||||||
| N | |||||||||||||||||||||||||||||
| 00 11e ld 0 |
'g 0! D |
O Q IO CO Cd Cd |
Q O |
O | O Cd |
to tg al N O 0 «! |
CD Cd Q «I CN |
Cd CD CD Cd |
|||||||||||||||||||||
| at0 g |
Lc | ||||||||||||||||||||||||||||
| ttl | |||||||||||||||||||||||||||||
| Ot 1«0 tll NC0 Ol 0 Pp |
N Cl 0 N |
O O Q 0 (D N O N |
O Q I 0 |
N CD 0 «I |
Q «I |
0! CD |
Cl Cd al ID |
o d O Cd |
CO | te al tD ID N Ol C (D |
o 0! |
te C! (D Cd |
|||||||||||||||||
| a!00 —E |
|||||||||||||||||||||||||||||
| 0 h 0 ta C al e dl V L Id |
td O N |
(O C! Cd |
Ct | ID N O O O |
O ca Cd |
CI C D Cd |
|||||||||||||||||||||||
| Id Jd |
I | ||||||||||||||||||||||||||||
| 11 | |||||||||||||||||||||||||||||
| tll | |||||||||||||||||||||||||||||
| (UO. | |||||||||||||||||||||||||||||
| O | Q IC L |
||||||||||||||||||||||||||||
| UlDZI-Z0 O LoI-Z IU UlI- I- Ill OZ Z U LU I-0I- M ILII-0Z |
Plo Al Ul Ch a LUa LU U.0 |
e 'D L 'D00 ID0 IL |
ca0 0 td Ol0 N Ct E 0 N'00 td dl0 Q 0 1d C ld 0 Q 0 N 1d0 d! E 8E dt |
Q Z N L 0 0C 0 al I— td Cd 1d th CJ |
E U. N dl (J at (d 0 at !— dt Ot CD O N NO O 0! d! ad dl 0 C dl0 CJ |
'D td tll0 E Q al Q0 N a! C E CJ L0 m 0 0 IL N L CJ L m UJ |
X0 | 0 D. m E c Cl «C ld) L Z |
OlL N dt 0 Yl0 1dC dle Q I!'. ca 1«L dt0. CD Q 0 Q Q CtE CJ D '0 tt! td dt td |
m Ep (0 ca L- '0 C UJ al dl 8 |
dt O!0 dtO dl 10 td N dl Val td ID at E & (! 0 0 al — tll 'd! 'oc E |
ld a! ca 0 td c 0 0 Ol L m ID |
0 a C L E 0 CU c D C 0 IL Ot 0 '0 td tll e |
N dt 0 tll Dl0 UJo 0 IL 0 E E CJ 0 tll 0 0 ttl Z eC |
o m E d ) Z 0 0 D C 0 |
It! a 0 NO m 0 Z OI) 2 Z Ol m c a— E c 0 td L IU0 0 0 ttt C '0 0 0 DL 0 0 IL N 0 N af I- CD |
0 0 Q td o C dl |
00 tll E 0 N d td E Ol N DlE a! JD E 0 c 0 UJ a 0 C L (3 |
| ID | L | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gl | ||||||||||||
| "0 Cl |
Ql Ql |
0 | ||||||||||
| 0 00O |
Z | S3 ID |
tD 0 O. E |
0O. O. Ul 0 |
||||||||
| Ut | CD | 0 | ||||||||||
| D | Z N3 Ul 'L & in 0 C 40 E Ul E 0!a O E h( &0 O m O (0 &h Ul0 S O Ul a c E 'E0 0 O. Ql a'0 N ID0 Gl ao Ol C C Ql C.& El N 0 D m L LU IL |
C Gl Z 3 Ol N C Gl Ol E 0 N Ol 0 Ol C Ut &0 CL E &00) DT 0 Zc 3 0 CD 0 O. 3 0S Cl.& 0 Ol &h E D Ql C &0(1. MS NC Ql Gl O. E0O Gl CD 0 Ct C Ql E N tU &" E C .Ol gl N O D C ID gl 0 O 00 0 0 CI 3 m &n N '0 O m &0 0 0 L C &0 Gt CD Ol Ut tUS &h0 40)E Z m 5 D CD C0!S Qt 0 O« a &0 O 0S Ol Ql ln N 0 o a N.E 0— L0 Gl ID NEW e' &h 0 00 Ql S a 0 eX«m ID omo S CI O m &0 "SN CL N 0 &0 0 CD O 0 L Ql N D 0'0 C a L IL QC u E Ql N N Gt Ql Gl0) x— SZ N40 WL C 0 N x In aE E Ul tU 0 N3 a S ED &0 C C S0 Ot C M &0cn 3 Qt E &E N Ih 'O D m &0 0 C tg O CD 00. CI Ul I/l C C Gl D Ql C C 0 —O Gl L 0 Ql E 0 0 DL N QlC— 0 3 " Ul 00.' 0 m e O NS O. .E In0 SC 0 0 Ul00— UtS In) O Z m3 In 0 mS C m 0 O (1 Gl Ql 0 L0 &D0 O. O. &U o 3 QDE c C 0 0 N 'c &0 S C S 0 E D) 0 N tU N 0— Ql Ql C CD &0 S 0 0 D m 0 N~ m «0 &U 0 CD C &D O ID 010 CD N N Ul D C —L N u Du 0 &U) EZ 'L C 0. In N) C Z m 4 Ul 0 ' NE S N m 0 Gl 0 0 m C! C am N S mc CDS UlL Ul 'c E tg L 40 ID IL IY |
Gt Z 0 O O O O gg (&I 0 C 0 0 N N N N E E C Gl &0 Z Z 3 3 Ql SC D D C C S Gl 0 0 0 0 0 0 CI CI Ql Ql a o. &0 &0 N N 0 0 0 0 Gl S 0 0 CI O. &0 Gl N N &0 m 3 3 0 0 CD OlLD C L IL IL 0 &D N E Gl &nN Ql 0 ID 0 ln Gl N(000 0 Gt0a C!. (0 uf CL0 O S ID C Ut &U 0 ' 0 CI E E m 0 O &D 0 Ul |
|||||||||
| ZI-z0V | Cl'0 N |
|||||||||||
| 'U | ||||||||||||
| CIII-z IU |
Io! | Cl N |
L IU Ol & C 0 Iu |
0! | ||||||||
| III | CD C(4 |
0 0 |
UlS0 | oO IL IL |
Gl E ID 0 |
|||||||
| (0 (n o z 0 Z |
e z 0 zE IL IUzI- o I- ILI o Z |
LII 5 o g a III ~ 4J o II. |
&0 C '0S0 W Cl &4 |
BO N N &tl 0 0) 0 IO 0 S 0c c N W Cl S Ul Ol 10 'U IO Io OO |
N mC E O C0 ln0 m O DL lg Cg 00 —IL olj L Ul 0 E SO m 0O Iu Ol C &0 cg CI |
C Gla 44 Gl 0 4l 0 &0 &«e ZK X 0 a X |
Ol E 0! S 4 0 IO0 C |
C0 '0 ID &0cu.c.c &, 0 c ,E —ot L" &0 Gl 0 Ufo. Ul. E —E ~S CI E E e oo5 0 m N c CO& e E 0 0,0 —o Emm Ufo' ' 2'Z 0 4l ugccc CC 01OUUOOO CCOO-IDD NIL IL C c L W OtotLgg Gl 0 0 lu m C C 0 0'i'i 0 0 DD mern«. o- m —IO IO Z S S Ul N =Dicer 22 5 C I- I- I- I- I"- Cl IL UlC'0 L Cl0!. V! S N LS J S E O |
&g N Z Ul C Z ea c E0 DCO Iu . C cee ogE 2 mo. 0 '0CSC 0 Gt 02(uc 0 0 C am In m 'C.— m& 2'0 Gl Ul uf)Q "6 |
| Analysis ofnet assets between funds | Unrestricted | Restricted | Endowment | Total |
|---|---|---|---|---|
| funds | funds | funds | ||
| 2022-23f | 2022-23f | 2022-23 F |
2022-23f | |
| Fund balances at30 June 2023 are represented | ||||
| by: | ||||
| Tangible assets Investments |
18,786 | 260,829 | 18,786 260,829 |
|
| Current assets/(liabilities) | 530,214 | 98,338 | 628,552 | |
| 549,000 | 98,338 | 260,829 | 908,167 | |
| Unrestricted | Restricted | Endowment | Total | |
| funds | funds | funds | ||
| 2021-22f | 2021-22f | 2021-22 f |
2021-22 f |
|
| Fund balances at30 June 2022 are represented | ||||
| by: | ||||
| Tangible assets Investments |
10,546 | 259,242 | 10,546 259,242 |
|
| Current assets/(liabilities) | 520,552 | 115,325 | 635,877 | |
| 531,098 | 115,325 | 259,242 | 905,665 |
| 27 | Cash generated from operations |
Cash generated from operations |
2022-23 | 2021-22 | ||||
|---|---|---|---|---|---|---|---|---|
| Surplus/(deficit) forthe year |
2,502 | (152,162) | ||||||
| Adjustments for: |
||||||||
| Investment income recognised |
in | statement | offinancial | activities | (7,745) | (2,897) | ||
| Depreciation and impairment |
oftangible | fixed assets | 9,064 | 13,072 | ||||
| Movements in working capital: |
||||||||
| (Increase)/decrease in stocks |
(22) | 8,454 | ||||||
| (Increase) in debtors | (28,692) | (126,319) | ||||||
| Increase/(decrease) in creditors |
33,969 | (53,206) | ||||||
| Increase in deferred income |
90,326 | |||||||
| Cash generated from/(absorbed |
by) operations | 99,402 | (313,058) |